Parallel Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-7
| Closed | -$2K | – | 3174 |
|
|
2021
Q1 | $2K | Hold |
7
| – | – | ﹤0.01% | 2563 |
|
|
2020
Q4 | $1K | Sell |
7
-23
| -77% | -$2.58K | ﹤0.01% | 2540 |
|
|
2020
Q3 | $3K | Hold |
30
| – | – | ﹤0.01% | 2244 |
|
|
2020
Q2 | $3K | Hold |
30
| – | – | ﹤0.01% | 2147 |
|
|
2020
Q1 | $2K | Sell |
30
-37
| -55% | -$3.92K | ﹤0.01% | 2210 |
|
|
2019
Q4 | $7K | Hold |
67
| – | – | ﹤0.01% | 1886 |
|
|
2019
Q3 | $8K | Buy |
67
+23
| +52% | +$3.49K | ﹤0.01% | 1781 |
|
|
2019
Q2 | $8K | Sell |
44
-5
| -10% | -$865 | ﹤0.01% | 1690 |
|
|
2019
Q1 | $8K | Buy |
49
+17
| +53% | +$2.53K | ﹤0.01% | 1642 |
|
|
2018
Q4 | $3K | Sell |
32
-64
| -67% | -$8.4K | ﹤0.01% | 1812 |
|
|
2018
Q3 | $17K | Buy |
96
+35
| +57% | +$5.05K | ﹤0.01% | 1230 |
|
|
2018
Q2 | $8K | Buy |
61
+30
| +97% | +$4.26K | ﹤0.01% | 1449 |
|
|
2018
Q1 | $3K | Hold |
31
| – | – | ﹤0.01% | 1779 |
|
|
2017
Q4 | $4K | Sell |
31
-54
| -64% | -$6.34K | ﹤0.01% | 1695 |
|
|
2017
Q3 | $10K | Sell |
85
-9
| -10% | -$964 | ﹤0.01% | 1308 |
|
|
2017
Q2 | $11K | Buy |
94
+24
| +34% | +$2.58K | ﹤0.01% | 1296 |
|
|
2017
Q1 | $8K | Hold |
70
| – | – | ﹤0.01% | 1335 |
|
|
2016
Q4 | $8K | Buy |
+70
| New | +$8.43K | ﹤0.01% | 1216 |
|
Other funds holding GWPH
Parallel Advisors's GWPH Position: Q2 2021 in Review
Parallel Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 7 shares — an estimated $2K sold.
Parallel Advisors first reported a position in GWPH in Q4 2016 and held it in 18 quarters. The position peaked at $17K in Q3 2018. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Parallel Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Parallel Advisors sold 7 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $2K.
- Parallel Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2016 and held it in 18 quarters.
- Parallel Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $17K in Q3 2018.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.